Marquette Asset Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.84K Buy
13
+8
+160% +$4.49K ﹤0.01% 379
2026
Q1
$2.81K Sell
5
-17
-77% -$10.9K ﹤0.01% 463
2025
Q4
$14.9K Buy
22
+11
+100% +$7.49K ﹤0.01% 184
2025
Q3
$7.03K Buy
+11
New +$6.68K ﹤0.01% 272
2023
Q4
Sell
-33
Closed -$14.4K 241
2023
Q3
$14.4K Sell
33
-8
-20% -$3.99K ﹤0.01% 194
2023
Q2
$20.6K Buy
+41
New +$19.6K 0.01% 184

Other funds holding IDXX

Marquette Asset Management's IDXX Position: Q2 2026 in Review

Marquette Asset Management increased its Idexx Laboratories (IDXX) stake by 160% in Q2 2026, buying an estimated $4.49K and bringing the position to 13 shares worth $6.84K. The position accounts for ﹤0.01% of the portfolio, ranked #379.

Marquette Asset Management first reported a position in IDXX in Q2 2023 and has held it in 6 quarters since. The position peaked at $20.6K in Q2 2023. 594 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Marquette Asset Management held 13 shares of Idexx Laboratories worth $6.84K as of Q2 2026.
  • Marquette Asset Management bought 8 Idexx Laboratories shares in Q2 2026, an estimated $4.49K.
  • Idexx Laboratories made up ﹤0.01% of Marquette Asset Management's portfolio in Q2 2026, its #379 holding.
  • Marquette Asset Management first reported a position in Idexx Laboratories in Q2 2023 and has held it in 6 quarters since.
  • Marquette Asset Management's Idexx Laboratories position peaked at $20.6K in Q2 2023.
  • 594 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Marquette Asset Management's 13F filing for Q2 2026, filed 9 Jul 2026.